Pfizer Steps Up Asia-Specific Drug Discovery for Tuberculosis
By PharmaDeals Analyst
Pharma Deals Review: Vol 2010 Issue 4 (Table of Contents)
Published: 23 Apr-2010
DOI: 10.3833/pdr.v2010.i4.1327 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
As part of its expansion in to emerging markets, Pfizer has started an Asia-specific diseases programme targeting multi drug resistant tuberculosis in partnership with Cumencor Pharmaceuticals and MicuRx Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS